可编辑文档-医药生物行业市场前景及投资研究报告：2024年医保谈判主要品种.ppt

2024^10^180

TFSECURITIES

wiEEWim

2024^g{£?Wm0£16H-18HffiT,i^KtWBx

Wx^Wx(2024^5-6^)s$»f£(2024^7-8^)x^iWg(2024B8-9E).

(2024^9-m)x£tfb^Pfi££(2024^11E)olxgi|^±BinT-^tEK)M:(1)ifi3^[^E^««0)^@^§nnno(2)©B20246£300,A£W^£PtftWWMSo

W®$m«®lffin°nraA)574®,ftlifi333tMo(BIBSn5®,^^445®),@^196®,EW249

N

J£n°nW:1)PD-1^,IWx®»AWJi3WlmB®Wgiia«£aAmiWJgo2)EGFRTKI^,

+,J^WJgffiSi^^££BA^^ftW,2024«M±miM^BJgMJgWJgBA^a«®,Pg^WJgWW^kW,BTKffl®ftl,ALK»MPCSK9|B^l^n°n#^±n°n^±^arl5n°n#^o

i^a=

AKA^BB^faW3«B®S(BA)xHWRi(BK)x®WJ^W7l(^9+Wril^)x(«m)xH

asmoj#(»®g)siiwu(^)xw«(^);oij«x^Bg(^m),£»

(WnSJ^);misWJg(MB),»£!?:SftAWg(BA)x#®^WJg(BA),

mu®■.B*fiA«®(BA),(Z^fiWk:W##±(^+WnS^),(W^:®*«(«m),®_bW:WBKB(Mft),©Mf^ilk:00-3WSHB(2%)tyfcffllMO(16)/W#f(16%)(BA)xMB8»(16AA-II)/®^^(48%)BW

(ba)xstfffl»WEWftmw®(wx),^^§te?L/aa^(i6)/m^(36%w^(^)x;±m^w/5%®wBi±U$(*££)),©BazS:PqJ®^±B^Stt±tfe¥(BA)x^iWJ)T(W^)o

jwawsa^w—(ba)x^w/gmi®m)x$^BBg(ba)2Wj»:®jtjg®w(ba)x(wx).(ba).wmjsw^),

(BA)xx(^)xTWKl(^),PqJ^WJg(^)xM^WJg(^9)xRZ=

B®ftk(^),®»:(BA)x®K5mW»iJJS:«AWg(§^J)□

;WaWSBd®®i£W^:(siRNA)(BA)x(^+in®^);©WUra:PWg()x

}§WJg(^J),)JISHW(BA),(WWS:MBWg(is^iJXW(^MffiB)o

a^;±:n^mix-©s^x*s±wji5(h)x(h).tiixwis^iksjbssemi(h)o

JXIPJIZF:jK®®4fiJxlP^,^WfSBPJXlPvz,BISB^JXlP^

§i989*m1993^,sh+teffliiM«

£z$wwjrFiw^,b^t“«^”

i998^,IE^^T±^MKTS^|§m^P^iJJM^o

2007^,S^£W^$UZA^»^±lWWaK®*E

m^eiJjMo2oi2^,At±gPxMBtPxp^pg^m^^wa^wsOoiw,p£^b£t

^«^§(DRG)^a^^jtjam«^Mswj^,wo±ja^o2oi8^ew®B^,maAtt^sm^s^

xR^P^pne^E^PtwiWxMffiT^,^tWifi

«S^K*AJTA?EP^[l^mR^nana^A»®ffiMAAgfiWn^^,IW“4+7

4^2023^8^,20193A2020^,tBDRG/DIPH^^^Bo

a:

if

XMiilS

riffle¥fWQ4SS?FgfO

Djl

H?

jaf

Sono

limllntnn

So

I5R

B

St

flu

-e

2

□

Hl

PR

§0

i

B

PRHiSo

gf



tffK°Saw

B■^h11NnTo

HO

^B»□□W

HD#

£0

«BM

O

M

■ffr

Sonnia-iSnLwffi

^1

Mtfr—So

BnB

o

WFfr

Mol^0=^